Echocardiographic prevalence of mitral and/or aortic regurgitation in patients exposed to either fenfluramine-phentermine combination or to dexfenfluramine
- 1 December 1999
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 84 (11) , 1335-1338
- https://doi.org/10.1016/s0002-9149(99)00567-6
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- A Population-Based Study of Appetite-Suppressant Drugs and the Risk of Cardiac-Valve RegurgitationNew England Journal of Medicine, 1998
- The Prevalence of Cardiac Valvular Insufficiency Assessed by Transthoracic Echocardiography in Obese Patients Treated with Appetite-Suppressant DrugsNew England Journal of Medicine, 1998
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Carcinoid Heart DiseaseCirculation, 1995
- Valve Disease Associated with Ergot Alkaloid Use: Echocardiographic and Pathologic CorrelationsAnnals of Internal Medicine, 1992
- Color Doppler evaluation of valvular regurgitation in normal subjects.Circulation, 1988
- Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation.Circulation, 1984
- A Double-blind Clinical Trial in Weight ControlArchives of internal medicine (1960), 1984
- Morphology of the Human Mitral ValveCirculation, 1970